Safety and efficacy of omalizumab for antihistamine-resistant chronic urticaria in children: a case series and literature review
出版年份 2023 全文链接
标题
Safety and efficacy of omalizumab for antihistamine-resistant chronic urticaria in children: a case series and literature review
作者
关键词
-
出版物
World Journal of Pediatrics
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2023-09-19
DOI
10.1007/s12519-023-00760-4
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Psychiatric comorbidities in children and adolescents with chronic urticaria
- (2022) George N. Konstantinou et al. World Journal of Pediatrics
- Efficacy and safety of omalizumab against chronic spontaneous urticaria: Real-world study from China
- (2022) Ao Wang et al. World Allergy Organization Journal
- The International EAACI/GA²LEN/EuroGuiDerm/APAAACI Guideline for the Definition, Classification, Diagnosis and Management of Urticaria
- (2021) T. Zuberbier et al. ALLERGY
- Expert consensus on the use of omalizumab in chronic urticaria in China
- (2021) Zuotao Zhao et al. World Allergy Organization Journal
- Omalizumab in children and adolescents with chronic spontaneous urticaria: Case series and review of the literature
- (2020) Stefano Passanisi et al. Dermatologic Therapy
- Efficacy and safety of treatment with omalizumab for chronic spontaneous urticaria ‐ a systematic review for the EAACI Biologicals Guidelines
- (2020) Ioana Agache et al. ALLERGY
- Severe chronic spontaneous urticaria in children – treatment options according to the guidelines and beyond – a 10 years review
- (2020) Petra Staubach et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Efficacy and tolerability of the updosing of second‐generation non‐sedating H1 antihistamines in children with chronic spontaneous urticaria
- (2020) Lucrezia Sarti et al. PEDIATRIC ALLERGY AND IMMUNOLOGY
- The global burden of chronic urticaria for the patient and society
- (2020) M. Gonçalo et al. BRITISH JOURNAL OF DERMATOLOGY
- Efficacy of omalizumab treatment for pediatric chronic spontaneous urticaria: A multi‐center retrospective case series
- (2020) Anne Ari et al. PEDIATRIC DERMATOLOGY
- Evaluating the efficacy of omalizumab therapy in a group of adolescents with chronic urticaria in real clinical practice
- (2020) Vera Kalugina et al. World Allergy Organization Journal
- Omalizumab in children and adolescents with chronic urticaria: A 16‐week real‐world study
- (2020) Xiao‐ting Song et al. ALLERGY
- Safety and effectiveness of omalizumab for the treatment of chronic urticaria in pediatric patients
- (2020) Coco Dekkers et al. PEDIATRIC ALLERGY AND IMMUNOLOGY
- Management of Chronic Urticaria in a Pediatric Population
- (2019) Sofianne Gabrielli et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Omalizumab for Chronic Urticaria in Children Less than 12 Years of Age: A Systematic Review.
- (2019) Taha Al-Shaikhly et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Prevalence of chronic urticaria in children and adults across the globe: systematic review with meta‐analysis
- (2019) Julia Fricke et al. ALLERGY
- Omalizumab for management of chronic urticaria in a pediatric population: a case-series
- (2018) Jason El Bilali et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Omalizumab for treating chronic spontaneous urticaria: an expert review on efficacy and safety
- (2017) Ana M Giménez-Arnau EXPERT OPINION ON BIOLOGICAL THERAPY
- How Often are Pediatric Patients with Clinically Amyopathic Dermatomyositis Truly Amyopathic?
- (2016) Edward J. Oberle et al. PEDIATRIC DERMATOLOGY
- Omalizumab for the Treatment of Chronic Idiopathic or Spontaneous Urticaria
- (2013) Marcus Maurer et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now